|
" Frontiers in Cardiovascular Health "
edited by Naranjan S. Dhalla, Arun Chockalingam, H. Ivan Berkowitz, Pawan K. Singal.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
734262
|
| Doc. No
|
:
|
b554093
|
| Main Entry
|
:
|
edited by Naranjan S. Dhalla, Arun Chockalingam, H. Ivan Berkowitz, Pawan K. Singal.
|
| Title & Author
|
:
|
Frontiers in Cardiovascular Health\ edited by Naranjan S. Dhalla, Arun Chockalingam, H. Ivan Berkowitz, Pawan K. Singal.
|
| Publication Statement
|
:
|
Boston, MA: Springer US, 2003
|
| Series Statement
|
:
|
Progress in experimental cardiology, 9.
|
| Page. NO
|
:
|
(xviii, 595 pages)
|
| ISBN
|
:
|
1461504554
|
|
|
:
|
: 9781461504559
|
| Contents
|
:
|
1. Inflammation and Cardiovascular Disease --;2. The Role of Inflammation in Cardiac Function and Repair --;3. Cardiac Repair Following Infarction --;4. Protein and Phospholipids Composition of Human Myocardium in Children with Congenital Heart Disease --;5. Human Atherosclerosis: New Participants? --;6. Aging and Dietary Lipids Modulate Ca2+-Dependent Mitochondrial Function in the Post-Ischemic Heart --;7. The Role of Nuclear Receptors in HDL Formation --;8. Vascular Complications in Diabetes: Risk Factors and Pathogenic Correlates --;9. Hypercholesterolemia and Cardiovascular Risk in Diabetic Patients --;10. Altered Substrate Utilization in the Diabetic Heart: Role of Lipoprotein Lipase --;11. Does Reperfusion Cause Any Injury to the Myocardium? --;12. Fulminant Myocarditis --;From Lethal Disease to Survival --;13. Homocysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study --;14. Drug Development Based on Functional Genomics of Overloaded Cardiomyocytes: CPT 1 vs. PPARalpha Effects of Etomoxir --;15. Mutational Profiles and Molecular Etiologies of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy in Asian Populations --;16. Flavanol-Rich Foods and Cardiovascular Health --;17. Benefits of Dietary Fiber for Cardiovascular Disease and Diabetes --;18. Nutrition and the Brain-Heart Connection --;19. Vitamin D and Atherosclerosis: A Noteworthy Link --;20. Congestive Heart Failure as Metabolic Disease --;21. Conditioned Nutritional Requirements: Therapeutic Relevance to Heart Failure --;22. Stress and Dietary Fat Influence Cell Membranes and Death Due to Ventricular Fibrillation and Heart Failure --;23. Pharmacotherapeutics of Diabetic Cardiomyopathy --;24. Atherosclerotic Regression --;A Myth or Reality --;25. Monolayers of Apolipoprotein AII at the Air/Water Interface --;26. Changing Partially Hydrogenated Fat for Palmitic Acid in the Diet Increases LDL-Cholesterol and Endogenous Cholesterol Synthesis in Normocholesterolemic Women --;27. Cytoprotection of Cardiac Myocytes by Polyunsaturated Fatty Acids --;28. The Effects of Taurine and Astragalus Membranaceus on Ion Currents and Their Expression in Cardiomyocytes After CVB3 Infection --;29. CoQ10 in the Treatment of Heart and Vascular Disease --;30. Global Burden of Cardiovascular Disease: Impending Pandemic in Developing Countries and Economies in Transition --;31. Cardiovascular Risk Factors in Women --;32. Cardiovascular Disease in Women in the Middle East --;33. Hypertension and Diabetes Situation in the Eastern Mediterranean Region: With Special Reference to Iran --;34. Coronary Artery Disease in Developing and Newly Industrialized Countries: A Scientific Statement of the International College of Cardiology --;35. Social Inequalities, Nutrition and Health --;36. The Potential Impact of Cardio Vision 2020 and Three Other Risk Factor Scenarios on Population Rates of Coronary Heart and Cardiovascular Disease: A Call to Action --;37. Benefits of Exercise in Patients with Congestive Heart Failure --;38. Cardiac Adaptations to Swim Exercise with Administration of a Cysteine Protease Inhibitor --;39. Reversal of Coronary Atherosclerosis by Yoga Lifestyle Intervention --;40. Prevention of Heart Failure --;A Clinical Reality? --;41. Diastolic Dysfunction, Redox Stress, Extracellular Matrix Remodeling and Congestive Heart Failure in Diabetes Mellitus.
|
| Abstract
|
:
|
The Frontiers in Cardiovascular Health varies between and within nations, depend- ing upon the level at which the battle is fought for better cardiovascular health. For example many of the African countries spend less than
|
| Subject
|
:
|
Cardiology.
|
| Subject
|
:
|
Epidemiology.
|
| Subject
|
:
|
Medicine.
|
| LC Classification
|
:
|
RA645.C34E358 2003
|
| Added Entry
|
:
|
Arun Chockalingam
|
|
|
:
|
H Ivan Berkowitz
|
|
|
:
|
Naranjan S Dhalla
|
|
|
:
|
Pawan K Singal
|
| |